HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

shuangshen ningxin

Networked: 6 relevant articles (2 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Plant Preparations: 622
    - Plant Extracts: 3916
      - Chinese Herbal Drugs: 73
        shuangshen ningxin: 6
Pharmaceutical Preparations
- Chinese Herbal Drugs: 73
  - shuangshen ningxin: 6

Experts

1.	Li, Xin-zhi: 2 articles (08/2007 - 08/2006)
2.	Liu, Jian-xun: 2 articles (08/2007 - 08/2006)
3.	Yu, Zhen: 2 articles (08/2007 - 08/2006)
4.	Fu, Jianhua: 1 article (01/2015)
5.	Guo, Hao: 1 article (01/2015)
6.	Han, Xiao: 1 article (01/2015)
7.	Hou, Jincai: 1 article (01/2015)
8.	Li, Lei: 1 article (01/2015)
9.	Lin, Chengren: 1 article (01/2015)
10.	Liu, Jianxun: 1 article (01/2015)

Related Diseases

1.	Myocardial Ischemia (Ischemic Heart Diseases) 09/01/2013 - "To investigate the effect of Shuangshen Ningxin (SSNX) formula on energy metabolism of myocardial ischemia/reperfusion rats. " 09/01/2013 - "[Effect of shuangshen ningxin formula on energy metabolism of myocardial ischemia/reperfusion rats]." 11/03/2023 - "Investigation of the active ingredients of Shuangshen Ningxin Fomula and the mechanism underlying their protective effects against myocardial ischemia-reperfusion injury by mass spectrometric imaging." 08/01/2007 - "[Protective effects of Shuangshen Ningxin capsule on miniature swine after myocardial ischemia by intervention]." 08/01/2007 - "To study the therapeutical effects of Shuangshen Ningxin capsule on miniature swine after myocardial ischemia by intervention. "
2.	Reperfusion Injury 11/03/2023 - "Investigation of the active ingredients of Shuangshen Ningxin Fomula and the mechanism underlying their protective effects against myocardial ischemia-reperfusion injury by mass spectrometric imaging." 09/20/2023 - "Shuangshen Ningxin capsule alleviates myocardial ischemia-reperfusion injury in miniature pigs by modulating mitophagy: network pharmacology and experiments in vivo."
3.	Thrombosis (Thrombus) 08/01/2007 - "Myocardial ischemic model miniature swine induced by self-thrombus via cardiac catheter in left anteriar descending coronary artery (LAD), were administrated Shuangshen Ningxin capsule for 6 days. " 08/01/2006 - "To investigate the establishment of mini-porcine myocardial ischemia (MI) model induced by thrombosis via cardiac catheterization intervention, and observe the anti-MI action of Shuangshen Ningxin Capsule (SNC). " 08/01/2006 - "[Effects of shuangshen ningxin capsule on mini-porcine myocardial ischemia model induced by thrombosis via cardiac catheterization intervention]." 08/01/2007 - "After being administered with shuangshen Ningxin capsule 6 days, the degree of self-thrombus blocked LAD reduced, hemodynamic indexes of CO, CI, LCW, LCWI and blood plasm superoxide dismutase (SOD) activity increased, and systemic vascular resistance (SVR), systemic vascular resistance index (SVRI) and malondialdehyde (MDA) content were lowed. "
4.	Cardiovascular Diseases (Cardiovascular Disease) 01/01/2015 - "Shuangshen Ningxin capsule (SSNX), a modern Chinese formula, has been used to treat cardiovascular diseases in Eastern Asia. "

Related Drugs and Biologics

1.	Capsules (Microcapsules)
2.	Superoxide Dismutase
3.	Membrane Lipids
4.	Malondialdehyde (Propanedial)

Related Therapies and Procedures

1.	Cardiac Catheters